Dynavax Technologies Corporation (DVAX) has a market capitalization of $1.82B and trades at $15.50. The 52-week range is 9.2-15.73.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 73.8, Earnings Per Share (EPS) of $0.21, annual revenue of $277.25M.
The stock has a beta of 0.93, operates in the Healthcare sector.
